Literature DB >> 31791693

Endothelium-mediated contributions to fibrosis.

Xuetao Sun1, Blessing Nkennor2, Olya Mastikhina3, Kayla Soon3, Sara S Nunes4.   

Abstract

Fibrosis, characterized by abnormal and excessive deposition of extracellular matrix, results in compromised tissue and organ structure. This can lead to reduced organ function and eventual failure. Although activated fibroblasts, called myofibroblasts, are considered the central players in fibrosis, the contribution of endothelial cells to the inception and progression of fibrosis has become increasingly recognized. Endothelial cells can contribute to fibrosis by acting as a source of myofibroblasts via endothelial-mesenchymal transition (EndoMT), or by becoming senescent, by secretion of profibrotic mediators and pro-inflammatory cytokines, chemokines and exosomes, promoting the recruitment of immune cells, and by participating in vascular rarefaction and decreased angiogenesis. In this review, we provide an overview of the different aspects of fibrosis in which endothelial cells have been implicated.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EndoMT; Endothelial cell; Exosomes; Fibrosis; Senescence; Vascular rarefaction

Mesh:

Year:  2019        PMID: 31791693     DOI: 10.1016/j.semcdb.2019.10.015

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  13 in total

Review 1.  Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction.

Authors:  Yong Wang; Juan Zhang; Zhen Wang; Cheng Wang; Dufang Ma
Journal:  Heart Fail Rev       Date:  2022-03-09       Impact factor: 4.214

2.  Single-cell RNA-seq reveals a critical role of novel pro-inflammatory EndMT in mediating adverse remodeling in coronary artery-on-a-chip.

Authors:  Peng Zhao; Qingzhou Yao; Pei-Jian Zhang; Erlinda The; Yufeng Zhai; Lihua Ao; Michael J Jarrett; Charles A Dinarello; David A Fullerton; Xianzhong Meng
Journal:  Sci Adv       Date:  2021-08-20       Impact factor: 14.136

3.  Endothelial-Mesenchymal Transition in Heart Failure With a Preserved Ejection Fraction: Insights Into the Cardiorenal Syndrome.

Authors:  María Valero-Muñoz; Albin Oh; Elizabeth Faudoa; Rosa Bretón-Romero; Fatima El Adili; Andreea Bujor; Flora Sam
Journal:  Circ Heart Fail       Date:  2021-08-19       Impact factor: 10.447

Review 4.  Endothelial Autophagy in Coronary Microvascular Dysfunction and Cardiovascular Disease.

Authors:  Fujie Zhao; Ganesh Satyanarayana; Zheng Zhang; Jianli Zhao; Xin-Liang Ma; Yajing Wang
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 5.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

6.  Dual Function of iPSC-Derived Pericyte-Like Cells in Vascularization and Fibrosis-Related Cardiac Tissue Remodeling In Vitro.

Authors:  Monika Szepes; Anna Melchert; Julia Dahlmann; Jan Hegermann; Christopher Werlein; Danny Jonigk; Axel Haverich; Ulrich Martin; Ruth Olmer; Ina Gruh
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

Review 7.  The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy.

Authors:  Nicolas Ricard; Sabine Bailly; Christophe Guignabert; Michael Simons
Journal:  Nat Rev Cardiol       Date:  2021-02-24       Impact factor: 32.419

Review 8.  Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches.

Authors:  Begoña López; Susana Ravassa; María U Moreno; Gorka San José; Javier Beaumont; Arantxa González; Javier Díez
Journal:  Nat Rev Cardiol       Date:  2021-02-10       Impact factor: 32.419

Review 9.  Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis.

Authors:  Denisa Baci; Annalisa Bosi; Luca Parisi; Giuseppe Buono; Lorenzo Mortara; Giuseppe Ambrosio; Antonino Bruno
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

10.  Ginsenoside Rg1 ameliorates aging‑induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice.

Authors:  Yan Li; Duoduo Zhang; Lan Li; Yuli Han; Xianan Dong; Liu Yang; Xuewang Li; Weizu Li; Weiping Li
Journal:  Mol Med Rep       Date:  2021-09-15       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.